Trades on 1 secondary market
Vivace Therapeutics
Vivace Therapeutics is a clinical-stage, oncology-focused biotechnology company based in the San Francisco Bay Area, developing small-molecule cancer therapeutics that target the Hippo-YAP signaling pathway. Its lead candidate, VT3989, is in clinical trials for mesothelioma and other solid tumors. T
Vivace Therapeutics is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.